Literature DB >> 898450

Cystitis glandularis.

G Davies, J E Castro.   

Abstract

We present 12 cases of cystitis glandularis which fall into two distinct groups, one characterized by hematuria and the other by urinary tract infection. We can produce no clinical evidence that this disease is premalignant, but emphasize the necessity of histology to exclude malignancy since, macroscopically, the condition is indistinguishable from mitotic changes. We also describe the association of cystitis glandularis and pelvic lipomatosis.

Entities:  

Mesh:

Year:  1977        PMID: 898450     DOI: 10.1016/0090-4295(77)90009-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma.

Authors:  Zhongxing Li; Guangcheng Ge; Rui Feng; Dan Wu; Bin Shen; Xing Wang; Yan Cui; Junrong Li; Xiaobing Ju
Journal:  BMC Urol       Date:  2014-01-03       Impact factor: 2.264

2.  Fibroblast growth factor-10 signals development of von Brunn's nests in the exstrophic bladder.

Authors:  Rocky Eastman; Elizabeth M Leaf; Dianzhong Zhang; Lawrence D True; Robert M Sweet; Kristy Seidel; Joseph R Siebert; Richard Grady; Michael E Mitchell; James A Bassuk
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-18

3.  Incidence of adenocarcinoma bladder in patients with cystitis cystica et glandularis: A retrospective study.

Authors:  Amit Agrawal; Deepak Kumar; Aditya A Jha; Puneet Aggarwal
Journal:  Indian J Urol       Date:  2020-10-01

4.  A pilot study on intravesical administration of curcumin for cystitis glandularis.

Authors:  Qiong Lu; Fen Jiang; Ran Xu; Xiao-Kun Zhao; Zhao-Hui Zhong; Lei Zhang; Hong-Yi Jiang; Lu Yi; Yi Hou; Xuan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-22       Impact factor: 2.629

5.  Cystitis glandularis: A controversial premalignant lesion.

Authors:  Xianlin Yi; Haoyuan Lu; Yuexian Wu; Yang Shen; Qinggui Meng; Jiweng Cheng; Yong Tang; Fengxue Wu; Rubiao Ou; Shaojun Jiang; Xianzhong Bai; Keji Xie
Journal:  Oncol Lett       Date:  2014-07-18       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.